Global /United Kingdom /Healthcare /Biotechnology /CMPS

COMPASS Pathways plc

CMPS

• NASDAQ: CMPS • Delayed

8.38USD -0.7%

As of 5 June 2026, COMPASS Pathways plc has a market cap of $1.13B USD, ranking #10031 globally and #250 in the United Kingdom. It ranks #882 in the Healthcare sector, and #163 in the Biotechnology industry.

Global Rank

10031

Country Rank

250

Sector Rank

882

Industry Rank

163

Key Stats

Market Cap

$1.13BUSD

Enterprise Value

$1.0BUSD

EBITDA (TTM)

-$175.07MUSD

Net Income (TTM)

-$287.86MUSD

Company Profile

Country (HQ)

United Kingdom

Sector

Healthcare

Industry

Biotechnology

CEO

Kabir Nath open_in_new

Employees

156

Founded

2020

IPO

18 Sep 2020

Website

compasspathways.com open_in_new

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.7%	-4.2%	56%	25%	28%	21%	116%	4.5%	-77%

News

CMPS Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	CMPS Compass Pathways PLC ADR ISIN: US20451W1018 Shares Out.: Shares Outstanding: 134.923M¹ Shares Float: 128.737M² TV: TradingView: NASDAQ: CMPS SA: Stock Analysis: NASDAQ: CMPS YF: Yahoo Finance: CMPS GF: Google Finance: NASDAQ: CMPS NQ: NASDAQ: CMPS BA: Barron's: CMPS MS: Morningstar: XNAS: CMPS	8.38 USD	TV: TradingView: NASDAQ: CMPS SA: Stock Analysis: NASDAQ: CMPS YF: Yahoo Finance: CMPS GF: Google Finance: NASDAQ: CMPS NQ: NASDAQ: CMPS BA: Barron's: CMPS MS: Morningstar: XNAS: CMPS
Frankfurt Stock Exchange (FRA) MIC: XFRA	5Y6 Compass Pathways PLC ADR ISIN: US20451W1018 TV: TradingView: FWB: 5Y6 SA: Stock Analysis: FRA: 5Y6 YF: Yahoo Finance: 5Y6.F GF: Google Finance: FRA: 5Y6 BA: Barron's: 5Y6 MS: Morningstar: XFRA: 5Y6	7.10 EUR	TV: TradingView: FWB: 5Y6 SA: Stock Analysis: FRA: 5Y6 YF: Yahoo Finance: 5Y6.F GF: Google Finance: FRA: 5Y6 BA: Barron's: 5Y6 MS: Morningstar: XFRA: 5Y6
Mexican Bolsa (BMV) MIC: XMEX	CMPS (CMPS/N) Compass Pathways PLC ADR ISIN: US20451W1018 TV: TradingView: BMV: CMPS SA: Stock Analysis: BMV: CMPS YF: Yahoo Finance: CMPS.MX GF: Google Finance: BMV: CMPS BA: Barron's: CMPS MS: Morningstar: XMEX: CMPS	242.00 MXN	TV: TradingView: BMV: CMPS SA: Stock Analysis: BMV: CMPS YF: Yahoo Finance: CMPS.MX GF: Google Finance: BMV: CMPS BA: Barron's: CMPS MS: Morningstar: XMEX: CMPS

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About COMPASS Pathways plc

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Similar Companies

Industry: Biotechnology (United Kingdom)

Name	Market Cap (USD) diff.	PE	Country
Verona Pharma plc NASDAQ: VRNA	$9.22B 715%	-	United Kingdom
Immunocore Holdings plc NASDAQ: IMCR	$1.42B 26%	-	United Kingdom
Oxford Biomedica plc LSE: OXB	$974.88M 726.61M GBP -14%	-	United Kingdom
Silence Therapeutics plc OTCMKTS: SLNCF	$265.93M -76%	-	United Kingdom
Diaceutics PLC LSE: DXRX	$195.92M 146.03M GBP -83%	-	United Kingdom
Scancell Holdings plc LSE: SCLP	$191.45M 142.69M GBP -83%	-	United Kingdom

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 16K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 14K%	19.0	United States
argenx SE EBR: ARGX	$48.01B 41.39B EUR 4K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.48B 68.19T KRW 4K%	35.5	South Korea
CSL Ltd. ASX: CSL	$43.01B 60.27B AUD 4K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.55B 33.71B CHF 4K%	37.2	Switzerland

chevron_leftBack